Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 534.12M
March 31, 2026 530.63M
December 31, 2025 528.18M
September 30, 2025 491.80M
June 30, 2025 432.83M
March 31, 2025 405.99M
December 31, 2024 396.51M
September 30, 2024 285.93M
June 30, 2024 280.88M
March 31, 2024 244.97M
December 31, 2023 233.81M
September 30, 2023 215.56M
June 30, 2023 202.73M
Date Value
March 31, 2023 192.23M
December 31, 2022 191.02M
September 30, 2022 174.07M
June 30, 2022 172.82M
March 31, 2022 171.08M
December 31, 2021 170.27M
September 30, 2021 168.64M
June 30, 2021 168.43M
March 31, 2021 168.32M
December 31, 2020 165.79M
September 30, 2020 168.32M
June 30, 2020 168.32M
March 31, 2020 168.32M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 62.67M
Absci Corp. 171.56M
Novavax, Inc. 164.82M
Editas Medicine, Inc. 153.53M
Amgen, Inc. 540.60M